TOTAL BIO TOTAL BIOAVAILABILITY Trademark

Trademark Overview

On Thursday, April 27, 2017, a trademark application was filed for TOTAL BIO TOTAL BIOAVAILABILITY with the United States Patent and Trademark Office. The USPTO has given the TOTAL BIO TOTAL BIOAVAILABILITY trademark a serial number of 87429012. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Tuesday, January 31, 2023. This trademark is owned by Ananda Scientific, Inc.. The TOTAL BIO TOTAL BIOAVAILABILITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, for the regulation of body systems, namely for diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases, like muscular dystrophy, Parkinson's disease, seizures type diseases, neurological disorders; therapeutics for health and well-being, namely pharmaceuticals, sprays, agents, edibles in the nature of pills and tablets, for the treatment of weight control, appetite suppression, muscle relaxation, sleep disorders; nutritional supplements
total bio total bioavailability

General Information

Serial Number87429012
Word MarkTOTAL BIO TOTAL BIOAVAILABILITY
Filing DateThursday, April 27, 2017
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateTuesday, January 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the words "TOTAL BIO" in blue in a white circle and the words TOTAL BIOAVAILABILITY in white in a blue hexagonal surround.
Goods and ServicesPharmaceuticals, for the regulation of body systems, namely for diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases, like muscular dystrophy, Parkinson's disease, seizures type diseases, neurological disorders; therapeutics for health and well-being, namely pharmaceuticals, sprays, agents, edibles in the nature of pills and tablets, for the treatment of weight control, appetite suppression, muscle relaxation, sleep disorders; nutritional supplements
Pseudo MarkTOTAL BIO TOTAL BIOAVAILABILITY
Indication of Colors claimedThe color(s) blue and white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOAVAILABILITY"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 4, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAnanda Scientific, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDraper, UT 84020

Trademark Events

Event DateEvent Description
Tuesday, January 31, 2023ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Tuesday, January 31, 2023ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Tuesday, January 31, 2023ABANDONMENT - AFTER EX PARTE APPEAL
Tuesday, January 31, 2023EXPARTE APPEAL TERMINATED
Thursday, November 17, 2022EX PARTE APPEAL-REFUSAL AFFIRMED
Thursday, December 16, 2021NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Thursday, December 16, 2021EXAMINERS STATEMENT E-MAILED
Thursday, December 16, 2021EXAMINERS STATEMENT - COMPLETED
Friday, October 22, 2021ASSIGNED TO EXAMINER
Friday, October 22, 2021ASSIGNED TO EXAMINER
Monday, October 18, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, May 17, 2021NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, May 17, 2021SUBSEQUENT FINAL EMAILED
Monday, May 17, 2021SUBSEQUENT FINAL REFUSAL WRITTEN
Thursday, April 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION WRITTEN
Monday, August 31, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 31, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, August 30, 2020ASSIGNED TO LIE
Monday, August 10, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 10, 2020EX PARTE APPEAL-INSTITUTED
Monday, August 10, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, August 10, 2020EXPARTE APPEAL RECEIVED AT TTAB
Monday, February 10, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, February 10, 2020FINAL REFUSAL E-MAILED
Monday, February 10, 2020FINAL REFUSAL WRITTEN
Monday, December 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 28, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 28, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 21, 2019NON-FINAL ACTION E-MAILED
Friday, June 21, 2019NON-FINAL ACTION WRITTEN
Thursday, May 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 15, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 15, 2018NON-FINAL ACTION E-MAILED
Thursday, November 15, 2018NON-FINAL ACTION WRITTEN
Monday, October 1, 2018ASSIGNED TO EXAMINER
Tuesday, August 21, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 20, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 19, 2018NON-FINAL ACTION E-MAILED
Monday, February 19, 2018NON-FINAL ACTION WRITTEN
Saturday, February 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 2, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 2, 2017NON-FINAL ACTION E-MAILED
Wednesday, August 2, 2017NON-FINAL ACTION WRITTEN
Monday, July 31, 2017ASSIGNED TO EXAMINER
Monday, July 24, 2017ASSIGNED TO EXAMINER
Friday, May 5, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 1, 2017NEW APPLICATION ENTERED

Related Keywords

total bioavailability disorders sleep pharmaceuticals namely diseases muscular disease sprays edibles agents